Carasent Ab · OMXSTO:CARA

Carasent Ab — Q2 2023 Earnings Presentation

16 slides from Carasent Ab's earnings presentation, Jul 14, 2023

  1. Slide 1: Interim report Q2 2023

    Interim report Q2 2023 14 July 2023

  2. Slide 2: Disclaimer

    Disclaimer Certain statements made in this Presentation may include forward-looking statements. These statements relate to the Company’s expectations, beliefs, intentions or strategies regarding the future. The forward-looking statements reflect the Company’s current views and assumptions with respe

  3. Slide 3: Agenda

    Agenda 1 Q2 highlights 2 Business and market update 3 Financial review

  4. Slide 4: Q2 Highlights

    €3 CARASENT Q2 Highlights

  5. Slide 5: Q2 2023 Summary

    Q2 2023 Summary 1 2 Revenue growth of Organic growth of 36% YoY 17% YoY 3 4 Cost savings program 31 clinics signed for completed successfully Webdoc in Sweden 5 Strong balance sheet with cash position of NOK 655 million

  6. Slide 6: Business and market update

    €3 CARASENT Business and market update

  7. Slide 7: Consistent track-record of growth

    Consistent track-record of growth ✓ Adj. EBITDA margin Adj. EBITDAC margin1 LTM revenue ✓ ✓ 63 60 57 ✓ 47 47 45 ✓ 40 37 32 28 20 17 18 16 36% 31% 40% 28% 33% 27% 23% 34% 15% 35% 31% 36% 8% 9% 18% 13% 8% 12% 7% 9% 7% -6% -10% -12% -18% -18% -28% -30% Q1-20 Q2-20 Q3-20 Q4-20 Q1-21 Q2-21 Q3-21 Q4-21 Q1

  8. Slide 8: Increased growth

    Increased growth Improved Outreach ”We´re back” Backlog deliveries selling (average 4,5) Development General New segments of marketing improvements

  9. Slide 9: Cost cutting program

    Cost cutting program ▪ Cost cutting program initiated and completed in the quarter, saving approximately 40 MNOK on an annual basis. One off costs of 4.2 MNOK in the quarter. ▪ Almost all of the savings are from fewer employees and consultants (32 FTE). All staff which are leaving as a result of the

  10. Slide 10: Financial Review

    €3 CARASENT Financial Review

  11. Slide 11: Q2 2023 Financial summary

    Q2 2023 Financial summary 1 2 3 Revenue growth of Organic growth of Organic recurring 36% YoY 17% YoY revenue growth of 14% YoY 4 5 6 Net retention rate of Adjusted EBITDA ARR of NOK 221m as 108% in Q2 margins of 9% in Q2 per Jun-23 Note: Organic growth rates are presented with constant currency rat

  12. Slide 12: Strong revenue growth – recurring revenues around 90% of total

    Strong revenue growth – recurring revenues around 90% of total Revenue development (NOKm) Key highlights Recurring revenues Consulting & other ▪ Sticky revenue base with recurring 63 60 57 revenues around 90% of total 47 47 revenues ▪ Organic growth was higher than 54 56 49 42 43 previous quarters b

  13. Slide 13: Organic recurring revenue growth of 14% in Q2 YoY

    Organic recurring revenue growth of 14% in Q2 YoY 1 Existing customer base New customers ▪ Net retention rate of 108% compared to Q2 2022 ▪ New customer growth of 6% Q2 YoY ▪ High stickiness and low churn rates maintained ▪ Strong market positions ▪ Strong potential remains for upsell ▪ Several meas

  14. Slide 14: Cost savings program completed during Q2 – full effect not reflected in figures

    Cost savings program completed during Q2 – full effect not reflected in figures Cash cost base Q1 2023 vs. Q2 2023 Comments ▪ Cash cost NOK 4 million lower in Q2 -4m compared to Q1 (6 million at constant 78 currency) 74 12 11 ▪ Cost savings program completed with estimated savings of ~40m per year 2

  15. Slide 15: Profitability and cash flow starting to improve

    Profitability and cash flow starting to improve Adjusted EBITDA development Capitalized development Adjusted cash EBITDA1 13 5 6 Q2-22 Q1-23 Q2-23 -9 -11 8% 9% -17 -18 -22 -23 Q2-22 Q1-23 Q2-23 Q2-22 Q1-23 Q2-23 X% Share of revenue Existing markets New initiatives 1: Adjusted EBITDA less capitalized

  16. Slide 16: Q&A

    Q&A fb 5 CARASENT GP

Carasent — Q2 2023 Earnings Presentation on 6ix